Dementia patients could benefit from a drug generally prescribed for cancer patients. According to researchers associated with the study, the drug offers benefits to patients suffering cognitive decline. This drug RGFP966 is used in the cancer therapy.
According to a new study, done by researchers of Rutgers University and the University of California, published in the Journal of Neuroscience, the same drug helps the brain in keeping the neurons alive.
Researchers applied the drug on rats and found that it helped them to keep and remember more information.